Pulmatrix - PULM Net Assets per Single Share

Graphic logo of Pulmatrix, Inc. (PULM)

Pulmatrix, Inc. is protected by patents for its drug delivery system, which, combined with strict FDA oversight, creates significant barriers to entry. The company generates revenue by treating patients with lung pathologies through insurance reimbursements and partnerships. Operating within the US legal framework ensures business security. Book value per share data demonstrates capital resilience, while the 0.44 level serves as a critical benchmark.

Pulmatrix Inc (PULM): Share Book Value from 07/04/2022 to 10/27/2026
Manufactured products of Pulmatrix

For Pulmatrix, Inc. (PULM), which is developing the iSPERSE platform and raising capital through licensing deals, the reported book value per share reflects the actual value of net assets per security. This indicator is calculated by dividing equity minus liabilities by the number of shares, allowing the investor to assess the business's internal margin of safety and the risk of overpaying when buying at historical peaks.

Competitors of Pulmatrix, Inc. (PULM)

HLN - Net Assets per Single Share|KVUE: Net Assets per Single Share|VRNA (Verona Pharma plc) - Net Assets per Single Share|MENS (jyongbio.com) - Accounting Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share ABVC (abvcpharma.com)|Cumberland Pharmaceuticals Inc. (CPIX) - Net Assets per Single Share|QNTM - Share Book Value|FibroGen Corp - Accounting Value per Share|TELO: Book Value per Share|ranitherapeutics.com (RANI) - Net Assets per Single Share|SNYR (Synergy CHC) - Net Assets per Single Share|Net Assets per Single Share RLYB|Accounting Value per Share Lexaria|Book Value per Share PTHL|Book Value per Share aptorumgroup.com APM|Accounting Value per Share Lyra Therapeutics, Inc. (LYRA)|Impact BioMedical, Inc. - Book Price of a Share|Net Assets per Single Share TNF Pharma (TNFA)|YCBD - Accounting Value of a Share|PainReform Limited - Book Value per Share|Net Assets per Share Altamira Therapeutics Ltd.|Accounting Value per Share Lipella Pharmaceuticals (LIPO)|Equity per Share optinose.com (OPTN)|Pieris Pharmaceuticals, Inc. (PIRS) - Accounting Value per Share|Accounting Value of a Share Procaps Group (PROC)|Book Value per Share PTPI|Qilian International Corp - Net Assets per Share|Acelyrin, Inc. (SLRN) - Net Assets per Single Share|TFFP - Equity per Share